International Clinical Trial: Extrafine ICS/LABA Versus As-Needed SABA for Small Airway Dysfunction in Symptomatic Patients With Preserved Spirometry

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07809555) titled 'Extrafine ICS/LABA Versus As-Needed SABA for Small Airway Dysfunction in Symptomatic Patients With Preserved Spirometry' on Sept. 3.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Yi-Han Hsiao

Condition: Small Airway Dysfunction

Intervention: Drug: Beclomethasone dipropionate/formoterol fumarate (extrafine)

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: August 12, 2021

Target Sample Size: 93

Countries of Recruitment: Taiwan

To know more, visi...